Determination of the target volume of HeLa cells treated with platinum-195m radiolabeled trans-diaminedichloroplatinum(II): a comparison with cis-diaminedichloroplatinum(II)
- 31 May 1993
- journal article
- research article
- Published by Elsevier BV in Nuclear Medicine and Biology
- Vol. 20 (4), 389-393
- https://doi.org/10.1016/0969-8051(93)90068-6
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- The Number of Platinum Atoms Binding to DNA, RNA and Protein Molecules of HeLa Cells Treated with Cisplatin at Its Mean Lethal ConcentrationJapanese Journal of Cancer Research, 1992
- Synthesis of195mPt radiolabeled (−)-(R)-2-aminomethyl-pyrrolidine (1,1-cyclobutanedicarboxylato)-2-platinum(II) monohydrate using high performance liquid chromatographyJournal of Radioanalytical and Nuclear Chemistry, 1992
- Synthesis of195mPt radiolabelled cis-diamminedichloroplatinum/II/ of high chemical and radiochemical purity using high performance liquid chromatographyJournal of Radioanalytical and Nuclear Chemistry, 1989
- Adducts of the antitumor drug cis-diamminedichloroplatinum(II) with DNA: formation, identification, and quantitationBiochemistry, 1985
- Detection and quantification of adducts formed upon interaction of diamminedichloroplatinum (II) with DNA, by anion-exchange chromatography after enzymatic degradationNucleic Acids Research, 1982
- COMBINATION CHEMOTHERAPY WITH CIS-DIAMMINE-DICHLORO-PLATINUM, VINBLASTINE, AND BLEOMYCIN IN ADVANCED TESTICULAR NON-SEMINOMAThe Lancet, 1979
- Cis-Diamminedichloroplatinum, Vinblastine, and Bleomycin Combination Chemotherapy in Disseminated Testicular CancerAnnals of Internal Medicine, 1977
- Interactions between mammalian cell DNA and inorganic platinum compounds—I: DNA interstrand cross-linking and cytotoxic properties of platinum(II) compoundsBiochemical Pharmacology, 1974